HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers

CONCLUSIONS: HER2 GPA can be used to accurately determine HER2 status in endometrial cancers and is a highly valuable tool for identifying HER2 heterogeneity.PMID:36857635 | DOI:10.1093/ajcp/aqac179
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Source Type: research